Show simple item record

Radotinib and its clinical potential in chronic-phase chronic myeloid leukemia patients: an update.

dc.contributor.authorEskazan, AHMET EMRE
dc.contributor.authorKeskin, Dilek
dc.date.accessioned2021-03-05T19:19:13Z
dc.date.available2021-03-05T19:19:13Z
dc.identifier.citationEskazan A. E. , Keskin D., "Radotinib and its clinical potential in chronic-phase chronic myeloid leukemia patients: an update.", Therapeutic advances in hematology, cilt.8, ss.237-243, 2017
dc.identifier.issn2040-6207
dc.identifier.othervv_1032021
dc.identifier.otherav_ceafb581-9c73-4821-9ed5-c786fd25deba
dc.identifier.urihttp://hdl.handle.net/20.500.12627/136719
dc.identifier.urihttps://doi.org/10.1177/2040620717719851
dc.language.isoeng
dc.titleRadotinib and its clinical potential in chronic-phase chronic myeloid leukemia patients: an update.
dc.typeMakale
dc.relation.journalTherapeutic advances in hematology
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume8
dc.identifier.startpage237
dc.identifier.endpage243
dc.contributor.firstauthorID180382


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record